Nesrin SARIMAN, Ender LEVENT, Attila SAYGI, Akın Cem SOYLU, Şirin YURTLU, Sümeyye ALPARSLAN

4659

Short-term positive airway pressure therapy response in obstructive sleep apnea patients: impact of treatment on the quality of life

Giriş: Çalışmamızda; obstrüktif uyku apne (OSA) tanısıyla pozitif hava yolu basıncı (PAP) tedavisi planlanan hastaların Calgary uyku apne yaşam kalitesi indeksi [Calgary Sleep Apnea Quality of Life Index (SAQLI)], Epworth uykululuk ölçe- ği (EUÖ) ve obstrüktif uyku apne sendromu (OSAS) semptom sorgu anketini kullanarak tedavi uyumunu değerlendirmeyi ve tedavinin yaşam kalitesi üzerine erken dönem etkilerini araştırmayı planladık. Hastalar ve Metod: Üniversite hastanesi Uyku Laboratuvarında; uyku ile ilgili yakınmaları nedeniyle polikliniğimize baş- vuran ve polisomnografi testi uygulanarak OSA tanısı almış, PAP cihazıyla devamlı PAP tedavisi planlanan, çalışmaya katılmayı kabul eden erişkin toplam 30 hasta (23ü erkek, 7si kadın) çalışmaya dahil edildi. Tüm olgulardan yazılı onam alındı. Bulgular: Olguların genel verileri, OSAS semptomları, EUÖ skorları ve SAQLI değerleri kaydedildi. Bir ay sonra yapılan ikinci görüşmede EUÖ, SAQLI ve OSAS semptom sorgulamaları yenilenerek hastaların kazanımları değerlendirildi. Çalış- maya alınan tüm hastaların bir ay süresince gece uyku boyunca cihazı kullandıkları saptandı. OSA olgularında PAP tedavisi ile gündüz aşırı uykululuk hali nde, semptom sorgulama anketi ve Calgary yaşam kalitesi anketi puanlarında anlamlı iyileşmeler (p< 0.001) elde edildi. Apne hipopne indeksi puanıyla tedavi sonucu elde edilen duygu durum deği- şiklikleri arasında anlamlı ilişki bulundu (r= -0.374, p= 0.045). Sonuç: OSA olgularının erken dönemde PAP tedavisinden kayda değer fayda sağlayabileceği saptanmıştır. Bu çalışma, hastaların hastalıklarıyla ilgili farkındalıklarının artmasını ve tedavi süresince tedavi kazanımlarını daha iyi algılamaları- nı sağlamıştır. OSAS ağırlığının tedaviyle elde edilen duygu durum değişikliklerinin belirleyicisi olduğu ve hastalığın ağırlığı ne kadar fazla ise PAP tedavisiyle duygu durumdaki düzelmelerin o kadar belirgin olduğu görülmüştür.

Obstrüktif uyku apne olgularında pozitif hava yolu basıncı tedavisine erken yanıtın değerlendirilmesi: Tedavinin yaşam kalitesi üzerine etkisi

Introduction: We aimed to assess the compliance of obstructive sleep apnea (OSA) patients of whom we planned positive airway pressure (PAP) therapy by using Calgary Sleep Apnea Quality of Life Index (SAQLI) , Epworth Sleepiness Score (ESS) , OSAS Symptoms Questionnaire (OSQ) and, to investigate the early effects of treatment on the quality of life. Patients and Methods: A total of 30 adult (male/female: 23/7) OSA patients who applied to Sleep Research Laboratory at the University Hospital, complaining of symptoms related to sleep and polysomnographically verified as OSAS with PAP therapy indications were included to the study. Their written consent were obtained. Results: Characteristics of the patients, OSAS symptoms, ESS and SAQLI sores were recorded. After a month, on the second visit, ESS, SAQLI and OSAS symptoms questionnaire had been repeated. All the patients have routinely used PAP devices for a period of a month. PAP therapy provided significant improvements in excessive daytime sleepiness, symptoms questionnaire and SAQLI scores (p< 0.001). There was a significant correlation between apnea hypopnea index (AHI) score and the improvements in emotional functioning (r = -0.374, p= 0.045). Conclusion: We concluded that the OSA patients can have remarkable benefits from PAP therapy during the early treatment period. This study increased the awareness of the patients about their illness and their perceived benefits related to PAP treatment. Emotional functioning improved prominantly as the disease s severity increased.
PDF

___

  • 1. Bollig SM. Encouraging CPAP adherence: it is everyone’s job. Respir Care 2010; 55: 1230-6.
  • 2. Giles TL, Lasserson TJ, Smith BH, White J, Wright JJ, Cates CJ. Continuous positive airways pressure for obstructive sleep apnoea in adults. Cochrane Database Syst Rev 2006; 3: CD001106.
  • 3. Olsen S, Smith S, Oei T. Adherence to continuous positive airway pressure therapy in obstructive sleep apnoea sufferers: a theoretical approach to treatment adherence and intervention. Clinical Psychology Review 2008; 28: 1355-71.
  • 4. Shapiro GK, Shapiro CM. Factors that influence CPAP adherence: an overview. Sleep Breath 2010; 14: 323-35.
  • 5. Sanders MH, Gruendl CA, Rogers RM. Patient compliance with nasal CPAP therapy for sleep apnea. Chest 1986; 90: 330- 3.
  • 6. Meslier N, Lebrun T, Grillier-Lanoir V, Rolland N, Henderick C, Sailly JC, et al. A French survey of 3.225 patients treated with CPAP for obstructive sleep apnoea: benefits, tolerance, compliance and quality of life. Eur Respir J 1998; 12: 185-92.
  • 7. Flemons WW, Reimer MA. Measurement properties of the Calgary Sleep Apnea Quality of Life Index. Am J Respir Crit Care Med 2002; 165: 159-64.
  • 8. Johns MW. A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep 1991; 14: 540-5.
  • 9. Epstein LJ, Kristo D, Strollo PJ, Friedman N, Malhotra A, Patil PS, et al. Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. Adult Obstructive Sleep Apnea Task Force of the American Academy of Sleep Medicine. J Clin Sleep Med 2009; 5: 263-76.
  • 10. Rechtschaffen A, Kales A. A manual of standardized terminology, techniques and scoring system for sleep satges in human subjects. CA: Brain Information Service, Los Angeles, UCLA, 1968.
  • 11. Iber C, Ancoli-Israel S, Chesson A, Quan SF. The AASM Manual for the scoring of sleep and associated events: rules, terminology and technical specifications. 1st ed. Westchester, IL: American Academy of Sleep Medicine 2007.
  • 12. Mc Ardle N, Douglas NJ. Effect of continuous positive airway pressure on sleep architecture in the sleep apnea–hypopnea syndrome. Am J Respir Crit Care Med 2001; 164: 1459-63.
  • 13. Sin DD, Mayers I, Man GCW, Ghahary A, Pawluk L. Can positive airway pressure therapy improve the general health status of patients with obstructive sleep apnea? A clinical effectiveness study. Chest 2002; 122: 1679-85.
  • 14. Berg S. Obstructive sleep apnoea syndrome: current status. Clin Respir J 2008; 2: 192-201.
  • 15. Kushida CA, Chediak A, Berry RB, Brown LK, Gozal D, Iber C, et al. Clinical guideliness for the manual titration of positive airway pressure in patients with obstructive sleep apnea. Positive Airway Pressure Titration Task Force of the American Academy of Sleep Medicine Task Force Members. J Clin Sleep Med 2008; 4: 157-71.
  • 16. McArdle N, Devereux G, Heidarnejad H, Engleman HM, Mackay TW, Douglas NJ. Long-term use of CPAP therapy for sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 1999; 159: 1108-14.
  • 17. Mc Nicholas WT. Diagnosis of obstructive sleep apnea in adults. Proc Am Thorac Soc 2008; 5: 154-60.
  • 18. Kribbs NB, Pack AI, Kline LR, Smith PL, Schwartz AR, Schubert NM, et al. Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnea. Am Rev Respir Dis 1993; 147: 887-95.
  • 19. Avlonitou E, Kapsimalis F, Varouchakis G, Varvadas CI, Behrakis P. Adherence to CPAP therapy improves quality of life and reduces symptoms among obstructive sleep apnea syndrome patients. Sleep Breath 2012; 16: 563-9.
  • 20. Pieters T, Collard P, Aubert G, Dury M, Delguste P, Rodenstein DO. Acceptance and long-term compliance with nCPAP in patients with obstructive sleep apnoea syndrome. Eur Respir J 1996; 9: 939-44.
  • 21. Becker HF, Jerrentrup A, Ploch T, Grote L, Penzel T, Sullivan CE, et al. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 2003; 107: 68-73.
  • 22. Mc Nicholas WT, Bonsignore MR. Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur Respir J 2007; 29: 156-78.
  • 23. Sanner BM, Klewer J, Trumm A, Randerath W, Kreuzer I, Zidek W. Long-term treatment with continuous positive airway pressure improves quality of life in obstructive sleep apnoea syndrome. Eur Respir J 2000; 16: 118-22.
  • 24. Bolitschek J, Schmeiser-Rieder A, Schobersberger R, Rosenberger A, Kunze M, Aigner K. Impact of nasal continuous positive airway pressure treatment on quality of life in patients with obstructive sleep apnoea. Eur Respir J 1998; 11: 890-4.
  • 25. Johns MW. Daytime sleepiness, snoring, and obstructive sleep apnea. The Epworth Sleepiness Scale. Chest 1993; 103: 30-6.
  • 26. Mc Nicholas WT. Compliance with nasal CPAP therapy for obstructive sleep apnoea: how much is enough? Eur Respir J 1997; 10: 969-70.
  • 27. Ashtyani H, Hutter DA. Collateral damage: the effects of obstructive sleep apnea on bed partners. Chest 2003; 124: 780-1.
  • 28. Waldhorn RE, Herrick TW, Nguyen MC, O'Donnell AE, Sodero J, Potolicchio SJ. Long-term compliance with nasal continuous positive airway pressure therapy of obstructive sleep apnea. Chest 1990; 97: 33-8.
  • 29. Meurice JC, Dore P, Paquereau J, Neau JP, Ingrand P, Chavagnat JJ, et al. Predictive factors of long-term compliance with nasal continuous positive airway pressure treatment in sleep apnea syndrome. Chest 1994; 105: 429-33.
  • 30. Engleman HM, Asgari-Jirhandeh N, McLeod AL, Ramsay CF, Deary IJ, Douglas NJ. Self-reported use of CPAP and benefits of CPAP therapy: a patient survey. Chest 1996; 109: 1470-6.
  • 31. Cruz IA, Drummond M, Winck JC. Obstructive sleep apnea symptoms beyond sleepiness and snoring: effects of nasal APAP therapy. Sleep Breath 2012; 16: 361-6.
  • 32. Jennum P. Quality of life, co-morbidity and obstructive sleep apnoea. Clin Respir J 2010; 4: 129-30.
  • 33. MunÄoz A, Mayoralas LR, Barbe F, PericaÂs J, Agustõ AGN. Long-term effects of CPAP on daytime functioning in patients with sleep apnoea syndrome. Eur Respir J 2000; 15: 676-81.
  • 34. Olsen S, Smith S, Oei T, Douglas J. Health belief model predicts adherence to CPAP before experience with CPAP. Eur Respir J 2008; 32: 710-17.
  • 35. Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea. Am J Respir Crit Care Med 2002; 165: 1217- 39.
  • 36. Fleury B, Rakotonanahary D, Hausser-Hauw C, Lebeau B, Guilleminault C. Objective patient compliance in long-term use of nCPAP. Eur Respir J 1996; 9: 2356-9.
  • 37. Flemons WW, Tsai W. Quality of life consequences of sleep-disordered breathing. J Allergy Clin Immunol 1997; 99: 750-6.
  • 38. Akashiba T, Kawahara S, Akahoshi T, Omori C, Saito O, Majima T, et al. Relationship between quality of life and mood or depression in patients with severe obstructive sleep apnea syndrome. Chest 2002; 122: 861-5.
Tüberküloz ve Toraks-Cover
  • ISSN: 0494-1373
  • Yayın Aralığı: 4
  • Başlangıç: 1951
  • Yayıncı: Tuba Yıldırım
Arşiv
Sayıdaki Diğer Makaleler

An extremely rare case of multiple calcifying tumor of the pleura

Ersin GÜNAY, Yetkin AĞAÇKIRAN, Sadi KAYA, Koray AYDOĞDU, Göktürk FINDIK, Sibel GÜNAY

Evaluation of inhaler technique and patient satisfaction with fixed-combination budesonide/formoterol dry-powder inhaler in chronic obstructive pulmonary disease (COPD): data on real-life clinical practice in Turkey

Akın KAYA, Cahit BİLGİN, Mehmethan TURAN, Özgür BATUM, Leyla YÜCESOY, Mustafa DEMİREL, Savaş YAŞAR, Bengü ŞAYLAN, Şeyma BAŞLILAR, Belgin İKİDAĞ, Murat ÇAM, Osman ALTIPARMAK, Tuncer ŞENOL, Kevser MELEK, Gonca CAN, Cahit DEMİR, Semih AĞANOĞLU, Şerife TORUN, Mustafa Ilgaz DOĞRUL, Nezaket ERDOĞAN, Muzaf

The trends of relevance about telling lung cancer diagnosis: social constraints, medical practice in several clinics

Sibel DORUK, Fidan SEVER, Can SEVİNÇ, Atila AKKOÇLU, Oya İTİL

KOAH değerlendirme testinin Türkçe geçerlilik ve güvenilirliği

Mehmet POLATLI, Eylem Sercan ÖZGÜR, Nilgün DEMİRCİ YILMAZ4, Sibel ATIŞ NAYCI, Arzu YORGANCIOĞLU, Ömer AYDEMİR, Atilla UYSAL, Selim Erkan AKDEMİR, Gamze KIRKIL, Nurdan KÖKTÜRK, Gonca GÜNAKAN

Compliance during continuous positive airway pressure therapy in obstructive sleep apnea syndrome: still looking for new factors

Cenk KIRAKLI, Antonio ESQUINAS

Nodüllerle seyreden skleroderma akciğer tutulumu

Sema YILMAZ, Zuhal EKİCİ, Tülay KIVANÇ, Füsun EYÜBOĞLU ÖNER

Inflammatory markers in exhaled breath condensate in patients with asthma and rhinitis

Hülyam KURT, İrfan DEĞİRMENCİ, Kurtuluş AKSU, Eren GÜNDÜZ, Emel KURT

The outcome of tuberculosis cases with persistent smear positivity at the end of extended initial phase

Haluk ÇALIŞIR, Nadi BAKIRCI, Gülgün ÇETİNTAŞ, Aylin BABALIK, Şule KIZILTAŞ, Korkmaz ORUÇ, Hülya ARDA

Aynı hastada üçüncü primer-ikinci metakron akciğer kanseri

Sadi KAYA, Abdulkadir KÜÇÜKBAYRAK, Koray AYDOĞDU, Seray HAZER, Göktürk FINDIK

EBUS-TBİA ile histopatolojik olarak granülomatöz hastalık tanısı alan olgularda polimeraz zincir reaksiyonunun önemi: Ön rapor

Hatice KILIÇ, Ayşegül ŞENTÜRK, Habibe HEZER, H. Canan HASANOĞLU, Ayşegül KARALEZLİ, Emine ARGÜDER